4K45 image
Deposition Date 2013-04-11
Release Date 2013-06-26
Last Version Date 2024-11-27
Entry Detail
PDB ID:
4K45
Title:
Auto-inhibition and phosphorylation-induced activation of PLC-gamma isozymes
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.50 Å
R-Value Free:
0.19
R-Value Work:
0.17
R-Value Observed:
0.16
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1
Gene (Uniprot):Plcg1
Chain IDs:A
Chain Length:106
Number of Molecules:1
Biological Source:Rattus norvegicus
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1, short peptide
Gene (Uniprot):Plcg1
Chain IDs:B
Chain Length:18
Number of Molecules:1
Biological Source:Rattus norvegicus
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
PTR B TYR O-PHOSPHOTYROSINE
Primary Citation
Autoinhibition and Phosphorylation-Induced Activation of Phospholipase C-gamma Isozymes.
Biochemistry 52 4810 4819 (2013)
PMID: 23777354 DOI: 10.1021/bi400433b

Abstact

Multiple extracellular stimuli, such as growth factors and antigens, initiate signaling cascades through tyrosine phosphorylation and activation of phospholipase C-γ (PLC-γ) isozymes. Like most other PLCs, PLC-γ1 is basally autoinhibited by its X-Y linker, which separates the X- and Y-boxes of the catalytic core. The C-terminal SH2 (cSH2) domain within the X-Y linker is the critical determinant for autoinhibition of phospholipase activity. Release of autoinhibition requires an intramolecular interaction between the cSH2 domain and a phosphorylated tyrosine, Tyr783, also located within the X-Y linker. The molecular mechanisms that mediate autoinhibition and phosphorylation-induced activation have not been defined. Here, we describe structures of the cSH2 domain both alone and bound to a PLC-γ1 peptide encompassing phosphorylated Tyr783. The cSH2 domain remains largely unaltered by peptide engagement. Point mutations in the cSH2 domain located at the interface with the peptide were sufficient to constitutively activate PLC-γ1, suggesting that peptide engagement directly interferes with the capacity of the cSH2 domain to block the lipase active site. This idea is supported by mutations in a complementary surface of the catalytic core that also enhanced phospholipase activity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures